Gary Ritchie

Gary Ritchie, InfraTrac [email protected], is director of Scientific Affairs at InfraTrac.

Articles by Gary Ritchie

3D printed pills and drugs, future of medicine. 3D Printing Drugs In Pharmacies. Multi-colored, various drugs, pills, capsules. Pharmaceutical medical concept | Image Credit: © irissca - © irissca - stock.adobe.com

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications

December 10th 2024

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.

Latest Updated Articles

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024

Gary Ritchie

Articles by Gary Ritchie

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications

Latest Updated Articles

Trending on Pharmaceutical Technology

GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines

EMA Approved 104 Human Medicines in 2025

Patient Access to Radiopharmaceuticals

USP Reports Drug Discontinuations on the Rise